ARAY
Accuray Incorporated
NASDAQ: ARAY · HEALTHCARE · MEDICAL DEVICES
$0.22
-3.54% today
Updated 2026-09-25
Market cap
$26.93M
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$0 – $2
Volume
0.9M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F3.8
Quality
D3.0
Profitability
D4.0
Valuation
C1/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →261 stocks currently score above 75
Price targets
Analyst target
$0.35
+62.72%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Free cash flow $1.97M — positive
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at -12.20%
- Revenue declining -20.90% QoQ
- Debt/equity 4.41x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $447.61M | $446.55M | $458.50M | $401.95M | $401.95M |
| Net income | $-9.28M | $-15.54M | $-1.59M | $-49.19M | $-1.94M |
| EPS | — | — | — | — | $-0.39 |
| Free cash flow | $2.86M | $-15.51M | $-5.66M | $-12.84M | $1.97M |
| Profit margin | -2.07% | -3.48% | -0.35% | -12.24% | -12.20% |
Peer comparison
Smart narrative
Accuray Incorporated trades at $0.22. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $401.95M. with profit margins at -12.20%.
Frequently asked questions
What is Accuray Incorporated's stock price?
Accuray Incorporated (ARAY) trades at $0.22, on a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Accuray Incorporated overvalued?
Accuray Incorporated carries a Smart Value Score of 37/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Accuray Incorporated (ARAY)?
The 12-month analyst consensus target is $0.35, about 62.7% above the current $0.22. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Accuray Incorporated's revenue?
Accuray Incorporated's trailing twelve-month revenue is $401.95M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.07x
ROE-110.60%
Beta1.39
50D MA$0.26
200D MA$0.47
Shares out0.12B
Float0.11B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—